OPTIMIZED Fc VARIANTS
US-2024026023-A1 · Jan 25, 2024 · US
This page is not indexed by search engines while we improve data quality.
Vafa Omid patents
Vafa Omid is listed as an inventor on 40 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Vafa Omid |
| Total patents | 40 |
| First publication | Jan 8, 2015 |
| Latest publication | Jan 25, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Optimized Fc variants
US-11820830-B2 · Nov 21, 2023 · US
Antibody Fc Mutants with Ablated Effector Functions
US-2021155711-A1 · May 27, 2021 · US
OPTIMIZED Fc VARIANTS
US-2021139600-A1 · May 13, 2021 · US
Antibody Fc mutants with ablated effector functions
US-10894836-B2 · Jan 19, 2021 · US
Fc variants with increased affinity for FcγRIIc
US-10584176-B2 · Mar 10, 2020 · US
Fc Variants with Increased Affinity for FcyRIIc
US-2019071512-A1 · Mar 7, 2019 · US
Optimized Fc variants and methods for their generation
US-10183999-B2 · Jan 22, 2019 · US
Optimized Fc variants and methods for their generation
US-10184000-B2 · Jan 22, 2019 · US
Novel immunoglobulin variants
US-2018360981-A1 · Dec 20, 2018 · US
Recent patents
Latest publications not already listed above.
Antibody Fc Mutants with Ablated Effector Functions
US-2018319893-A1 · Nov 8, 2018 · US
Fc variants with increased affinity for FcyRIIc
US-10113001-B2 · Oct 30, 2018 · US
Antibody Fc mutants with ablated effector functions
US-10053513-B2 · Aug 21, 2018 · US
OPTIMIZED Fc VARIANTS
US-2018208668-A1 · Jul 26, 2018 · US
Optimized fc variants and methods for their generation
US-2018141997-A1 · May 24, 2018 · US
Optimized Fc variants and methods for their generation
US-9714282-B2 · Jul 25, 2017 · US
Antibody Fc Mutants with Ablated Effector Functions
US-2017204193-A1 · Jul 20, 2017 · US
Novel immunoglobulin variants
US-2017166655-A1 · Jun 15, 2017 · US
Optimized Fc variants
US-9663582-B2 · May 30, 2017 · US
Optimized Fc variants
US-9657106-B2 · May 23, 2017 · US
Antibody Fc mutants with ablated effector functions
US-9637549-B2 · May 2, 2017 · US
OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION
US-2016347837-A1 · Dec 1, 2016 · US
OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION
US-2016347825-A1 · Dec 1, 2016 · US
Optimized fc variants
US-2016340436-A9 · Nov 24, 2016 · US
OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION
US-2016318993-A1 · Nov 3, 2016 · US
OPTIMIZED Fc VARIANTS
US-2016304589-A9 · Oct 20, 2016 · US
Optimized FC variants and methods for their generation
US-9353187-B2 · May 31, 2016 · US
Antibody Fc Mutants with Ablated Effector Functions
US-2015337053-A1 · Nov 26, 2015 · US
Optimized Fc variants and methods for their generation
US-9193798-B2 · Nov 24, 2015 · US
OPTIMIZED Fc VARIANTS
US-2015315284-A1 · Nov 5, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Xencor Inc | 31 |
| Janssen Biotech Inc | 9 |
| Vafa Omid | 2 |
| Strohl William | 1 |
| Lazar Gregory Alan | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/71 | 40 |
| C07K2317/732 | 40 |
| C07K16/2887 | 40 |
| C07K16/32 | 40 |
| C07K2317/92 | 39 |